TCM
CTSO icon

Tufton Capital Management’s Cytosorbents Corp CTSO Stock Holding History

Tufton Capital Management’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-12,000
Closed -$74K – 105
2015
Q2 		$74K Hold
12,000
– – 0.01% 100
2015
Q1 		$158K Hold
12,000
– – 0.03% 110
2014
Q4 		$119K Buy
+12,000
New +$118K 0.02% 115

Other funds holding CTSO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Tufton Capital Management's CTSO Position: Q3 2015 in Review

Tufton Capital Management sold out of Cytosorbents Corp (CTSO) in Q3 2015, closing a stake of 12,000 shares — an estimated $74K sold.

Tufton Capital Management first reported a position in CTSO in Q4 2014 and held it in 3 quarters. The position peaked at $158K in Q1 2015. 33 funds tracked by Wall St. Rank hold CTSO as of Q3 2015.

  • Tufton Capital Management reported no remaining Cytosorbents Corp position as of Q3 2015 after selling out during the quarter.
  • Tufton Capital Management sold 12,000 Cytosorbents Corp shares in Q3 2015, an estimated $74K.
  • Tufton Capital Management first reported a position in Cytosorbents Corp in Q4 2014 and held it in 3 quarters.
  • Tufton Capital Management's Cytosorbents Corp position peaked at $158K in Q1 2015.
  • 33 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2015.

Based on Tufton Capital Management's 13F filing for Q3 2015, filed 22 Oct 2015.